Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Rectosigmoid Cancer”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Post-approval studies (Phase 4)Ended earlyNCT00216424
What this trial is testing

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

Who this might be right for
Colorectal Cancer
James A. Haley Veterans Administration Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT04878094
What this trial is testing

Intra-operative Imaging in Women With Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian Carcinoma
Memorial Sloan Kettering Cancer Center 310
Testing effectiveness (Phase 2)Study completedNCT03043729
What this trial is testing

MFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer

Who this might be right for
Rectal CancerRectosigmoid Cancer
AIO-Studien-gGmbH 119
Not applicableStudy completedNCT03063918
What this trial is testing

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

Who this might be right for
Cancer SurvivorStage I Rectosigmoid CancerStage II Rectosigmoid Cancer+1 more
City of Hope Medical Center 10